DBV Technologies (DBVT) EPS (Diluted) Growth (3y) (2023 - 2026)
DBV Technologies (DBVT) EPS (Diluted) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 64.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64.37% |
| Mar 31, 2026 | 62.97% |
| Dec 31, 2025 | 60.14% |
| Sep 30, 2025 | 49.13% |
| Jun 30, 2025 | 55.30% |
| Mar 31, 2025 | 55.72% |
| Dec 31, 2024 | 54.32% |
| Sep 30, 2024 | 28.75% |
| Jun 30, 2024 | 32.44% |
| Mar 31, 2024 | -609.59% |
| Dec 31, 2023 | -379.46% |
| Sep 30, 2023 | -492.74% |
| Jun 30, 2023 | -482.18% |
| Mar 31, 2023 | -482.76% |